All-cause Mortality in Hemodialysis Patients with Heart Valve Calcification

Overview

Journal Clin J Am Soc Nephrol

Specialty Nephrology

Date 2011 Jun 25

PMID 21700824

Citations 42

Authors

Paolo Raggi

Antonio Bellasi

Christopher Gamboa

Emiliana Ferramosca

Carlo Ratti

Geoffrey A Block

Paul Muntner

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Calcification of the mitral and aortic valves is common in dialysis patients (CKD-5D). However, the prognostic significance of valvular calcification (VC) in CKD is not well established.

Design, Setting, Participants, & Measurements: 144 adult CKD-5D patients underwent bidimensional echocardiography for qualitative assessment of VC and cardiac computed tomography (CT) for quantification of coronary artery calcium (CAC) and VC. The patients were followed for a median of 5.6 years for mortality from all causes.

Results: Overall, 38.2% of patients had mitral VC and 44.4% had aortic VC on echocardiography. Patients with VC were older and less likely to be African American; all other characteristics were similar between groups. The mortality rate of patients with calcification of either valve was higher than for patients without VC. After adjustment for age, gender, race, diabetes mellitus, and history of atherosclerotic disease, only mitral VC remained independently associated with all-cause mortality (hazard ratio [HR], 1.73; 95% confidence interval [CI], 1.03 to 2.91). Patients with calcification of both valves had a two-fold increased risk of death during follow-up compared with patients without VC (HR, 2.16; 95% CI, 1.14 to 4.08). A combined CT score of VC and CAC was strongly associated with all-cause mortality during follow-up (HR for highest versus lowest tertile, 2.21; 95% CI, 1.08 to 4.54).

Conclusions: VC is associated with a significantly increased risk for all-cause mortality in CKD-5D patients. These findings support the use of echocardiography for risk stratification in CKD-5D as recently suggested in the Kidney Disease Improving Global Outcomes guidelines.

Citing Articles

Elevated concentrations of cardiac troponin T are associated with thoracic aortic calcification in non-dialysis chronic kidney disease patients of stage G3 to G5.

Zhu W, Lai Z, Xue M, Feng S, Feng P, Pan X Ren Fail. 2024; 47(1):2440512.

PMID: 39694530 PMC: 11656758. DOI: 10.1080/0886022X.2024.2440512.

Arterio-Venous Fistula Calcifications-Risk Factors and Clinical Relevance.

Grosu I, Stirbu O, Schiller A, Bob F Biomedicines. 2024; 12(11).

PMID: 39595030 PMC: 11591894. DOI: 10.3390/biomedicines12112464.

The Relationship between Circulating Kidney Injury Molecule-1 and Cardiovascular Morbidity and Mortality in Hemodialysis Patients.

Sircuta A, Grosu I, Schiller A, Petrica L, Ivan V, Schiller O Biomedicines. 2024; 12(8).

PMID: 39200365 PMC: 11352197. DOI: 10.3390/biomedicines12081903.

Exposure and outcomes of aortic valve change in patients initiating dialysis.

Kitamura M, Yamashita H, Sawase A, Takeno M, Maemura K, Mukae H Clin Exp Nephrol. 2024; 29(1):91-98.

PMID: 39168885 DOI: 10.1007/s10157-024-02548-w.

The association of peritoneal dialysis and hemodialysis on mitral and aortic valve calcification associated mortality: a meta-analysis.

Chiu K, Chen S, Su W, Chang Y, Chang K, Li C Sci Rep. 2024; 14(1):4748.

PMID: 38413701 PMC: 10899208. DOI: 10.1038/s41598-024-55326-9.

References

Panuccio V, Tripepi R, Tripepi G, Mallamaci F, Benedetto F, Cataliotti A . Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients. Am J Kidney Dis. 2004; 43(3):479-84. DOI: 10.1053/j.ajkd.2003.11.009. View

Fox C, Vasan R, Parise H, Levy D, ODonnell C, DAgostino R . Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study. Circulation. 2003; 107(11):1492-6. DOI: 10.1161/01.cir.0000058168.26163.bc. View

Callister T, Cooil B, Raya S, Lippolis N, Russo D, Raggi P . Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology. 1998; 208(3):807-14. DOI: 10.1148/radiology.208.3.9722864. View

Pohle K, Maffert R, Ropers D, Moshage W, Stilianakis N, Daniel W . Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation. 2001; 104(16):1927-32. DOI: 10.1161/hc4101.097527. View

Raggi P, Bommer J, Chertow G . Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer. J Heart Valve Dis. 2004; 13(1):134-41. View

Bellasi A, Ferramosca E, Muntner P, Ratti C, Wildman R, Block G . Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int. 2006; 70(9):1623-8. DOI: 10.1038/sj.ki.5001820. View

Block G, Spiegel D, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A . Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005; 68(4):1815-24. DOI: 10.1111/j.1523-1755.2005.00600.x. View

. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009; (113):S1-130. DOI: 10.1038/ki.2009.188. View

Ribeiro S, Ramos A, Brandao A, Rebelo J, Guerra A, Resina C . Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. Nephrol Dial Transplant. 1998; 13(8):2037-40. DOI: 10.1093/ndt/13.8.2037. View

10.

Yee-Moon Wang A, Ho S, Wang M, Liu E, Ho S, Kam-Tao Li P . Cardiac valvular calcification as a marker of atherosclerosis and arterial calcification in end-stage renal disease. Arch Intern Med. 2005; 165(3):327-32. DOI: 10.1001/archinte.165.3.327. View

11.

Sharma R, Pellerin D, Gaze D, Mehta R, Gregson H, Streather C . Mitral annular calcification predicts mortality and coronary artery disease in end stage renal disease. Atherosclerosis. 2006; 191(2):348-54. DOI: 10.1016/j.atherosclerosis.2006.03.033. View

12.

Otto C, Lind B, Kitzman D, Gersh B, Siscovick D . Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999; 341(3):142-7. DOI: 10.1056/NEJM199907153410302. View

13.

Yee-Moon Wang A, Woo J, Lam C, Wang M, Chan I, Gao P . Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant. 2005; 20(8):1676-85. DOI: 10.1093/ndt/gfh891. View

14.

Mazzaferro S, Coen G, Bandini S, Borgatti P, Ciaccheri M, Diacinti D . Role of ageing, chronic renal failure and dialysis in the calcification of mitral annulus. Nephrol Dial Transplant. 1993; 8(4):335-40. View

15.

Yee-Moon Wang A, Wang M, Woo J, Lam C, Kam-Tao Li P, Lui S . Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol. 2002; 14(1):159-68. DOI: 10.1097/01.asn.0000038685.95946.83. View

16.

Floege J, Raggi P, Block G, Urena Torres P, Csiky B, Naso A . Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients. Nephrol Dial Transplant. 2010; 25(6):1916-23. DOI: 10.1093/ndt/gfp762. View

17.

Raggi P, Giachelli C, Bellasi A . Interaction of vascular and bone disease in patients with normal renal function and patients undergoing dialysis. Nat Clin Pract Cardiovasc Med. 2006; 4(1):26-33. DOI: 10.1038/ncpcardio0725. View

18.

Achenbach S, Ropers D, Mohlenkamp S, Schmermund A, Muschiol G, Groth J . Variability of repeated coronary artery calcium measurements by electron beam tomography. Am J Cardiol. 2001; 87(2):210-3, A8. DOI: 10.1016/s0002-9149(00)01319-9. View

19.

Barasch E, Gottdiener J, Larsen E, Chaves P, Newman A . Cardiovascular morbidity and mortality in community-dwelling elderly individuals with calcification of the fibrous skeleton of the base of the heart and aortosclerosis (The Cardiovascular Health Study). Am J Cardiol. 2006; 97(9):1281-6. DOI: 10.1016/j.amjcard.2005.11.065. View

20.

Moe S, ONeill K, Duan D, Ahmed S, Chen N, Leapman S . Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int. 2002; 61(2):638-47. DOI: 10.1046/j.1523-1755.2002.00170.x. View